Schizophyllan inhibits the development of mammary and hepatic carcinomas induced by 7,12 dimethylbenz(α)anthracene and decreases cell proliferation: Comparison with tamoxifen

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 9, 2012, Pages 1579-1596

  Mansour, Ahmed ^a   Daba, Ayman ^b,c   Baddour, Nahed ^d   El Saadani, Muhammed ^a   Aleem, Eiman ^a,e  

^a Alexandria University Faculty Of Science   (Egypt)

^b Universities and Research Institutes District   (Egypt)

^c Fertility and Cryogenics   (United States)

^d ALEXANDRIA UNIVERSITY   (Egypt)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apoptosis; Breast cancer; Caspase 3; Hepatocellular carcinoma; Mushroom; Proliferating cell nuclear antigen; Schizophyllum commune; Tamoxifen

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CASPASE 3; CYCLINE; ESTROGEN RECEPTOR; SCHIZOPHYLLAN; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHYLLUM COMMUNE; TREATMENT DURATION; TUMOR GROWTH;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CASPASE 3; CELL PROLIFERATION; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS, EXPERIMENTAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTORS, ESTROGEN; SCHIZOPHYLLUM; SIZOFIRAN; SURVIVAL ANALYSIS; TAMOXIFEN;

EID: 84866735538     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1224-0     Document Type: Article

References (60)

1. Abraham RJ, Loftus P (1978) Proton and carbon-13 NMR spectros-copy: an integrated approach. Heyden, London
2. Akhondi-Meybodi M, Mortazavy-Zadah MR, Hashemian Z, Moaiedi M (2011) Incidence and risk factors for non-alcoholic steato-hepatitis in females treated with tamoxifen for breast cancer. Arab J Gastroenterol 12(1):34-36
3. Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol Off J US Can Acad Pathol Inc 11(2): 155-168
4. Axelrod R, Axelrod DE, Pienta KJ (2006) Evolution of cooperation among tumor cells. Proc Natl Acad SciUSA 103(36):13474-13479
5. Bernstein L, Deapen D, Cerhan JR, Schwartz SM, Liff J, McGann-Maloney E, Perlman JA, Ford L (1999) Tamoxifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst 91(19):1654-1662
6. Bohn JA, BeMiller JN (1995) (1- >3)-beta-D-glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydr Polym 28(1):3-14
7. Borchers AT, Stern JS, Hackman RM, Keen CL, Gershwin ME (1999) Mushrooms, tumors, and immunity. Proc Soc Exp Biol Med 221(4):281-293
8. Borchers AT, Keen CL, Gershwin ME (2004) Mushrooms, tumors, and immunity: an update. Exp Biol Med (Maywood) 229(5): 393-406
9. Burchiel SW, Davis DA, Ray SD, Barton SL (1993) DMBA induces programmed cell death (apoptosis) in the A20.1 murine B cell lymphoma. Fundam Appl Toxicol Off J Soc Toxicol 21(1): 120-124
10. Chihara G, Maeda Y, Hamuro J, Sasaki T, Fukuoka F (1969) Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes (Berk.) sing. Nature 222(5194):687-688
11. Chihara G, Hamuro J, Maeda Y, Arai Y, Fukuoka F (1970) Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing. (an edible mushroom). Cancer Res 30(11): 2776-2781
12. de Sousa JA, Facina G, da Silva BB, Gebrim LH (2006) Effects of low-dose tamoxifen on breast cancer biomarkers Ki-67, estrogen and progesterone receptors. Int Semin Surg Oncol ISSO 3:29
13. Di Cosimo S, Baselga J (2008) Targeted therapies in breast cancer: where are we now? Eur J Cancer 44(18):2781-2790
14. Dragan YP, Fahey S, Nuwaysir E, Sattler C, Babcock K, Vaughan J, McCague R, Jordan VC, Pitot HC (1996) The effect of tamoxifen and two of its non-isomerizable fixed-ring analogs on multistage rat hepatocarcinogenesis. Carcinogenesis 17(3): 585-594
15. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90(18):1371-1388
16. Frankfurt OS, Sugarbaker EV, Robb JA, Villa L (1995) Synergistic induction of apoptosis in breast cancer cells by tamoxifen and calmodulin inhibitors. Cancer Lett 97(2):149-154
17. Fu X, Latendresse JR, Muskhelishvili L, Blaydes BS, Delclos KB (2005) Dietary modulation of 7,12-dimethylbenz[a]anthracene (DMBA)-induced adrenal toxicity in female Sprague-Dawley rats. Food Chem Toxicol Int J Pub Br Ind Biol Res Assoc 43(5):765-774
18. Fu H, Guo WY, Yin H, Wang ZX, Li RD (2011) Inhibition of Lentinus edodes polysaccharides against liver tumour growth. Int J Phys Sci 6(1):116-120
19. Fujii T, Maeda H, Suzuki F, Ishida N (1978) Isolation and characterization of a new antitumor polysaccharide, KS-2, extracted from culture mycelia of Lentinus edodes. J Antibiot 31(11):1079-1090
20. Fujimoto S, Furue H, Kimura T, Kondo T, Orita K, Taguchi T, Yoshida K, Ogawa N (1991) Clinical outcome of postoperative adjuvant immunochemotherapy with sizofiran for patients with resectable gastric cancer: a randomised controlled study. Eur J Cancer 27(9):1114-1118
21. Garrity MM, Burgart LJ, Riehle DL, Hill EM, Sebo TJ, Witzig T (2003) Identifying and quantifying apoptosis: navigating technical pitfalls. Mod Pathol Off J U S Can Acad Pathol Inc 16(4):389-394
22. Greaves P, Goonetilleke R, Nunn G, Topham J, Orton T (1993) Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats. Cancer Res 53(17):3919-3924
23. Hard GC, Williams GM, Iatropoulos MJ (1993) Tamoxifen and liver cancer. Lancet 342(8868):444-445
24. Herold C, Ganslmayer M, Ocker M, Hermann M, Hahn EG, Schuppan D (2002) Combined in vitro anti-tumoral action of tamoxifen and retinoic acid derivatives in hepatoma cells. Int J Oncol 20(1):89-96
25. Inoue M, Tanaka Y, Sugita N, Yamasaki M, Yamanaka T, Minagawa J, Nakamuro K, Tani T, Okudaira Y, Karita T et al (1993) Improvement of long-term prognosis in patients with ovarian cancers by adjuvant sizofiran immunotherapy: a prospective randomized controlled study. Biotherapy 6(1):13-18
26. Ishizuka Y, Tsukada H, Gejyo F (2004) Interference of (1- >3)-beta-D-glucan administration in the measurement of plasma (1- >3)-beta-D-glucan. Intern Med 43(2):97-101
27. Jones LP, Li M, Halama ED, Ma Y, Lubet R, Grubbs CJ, Deng CX, Rosen EM, Furth PA (2005) Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer. Oncogene 24(22):3554-3562
28. Killackey MA, Hakes TB, Pierce VK (1985) Endometrial adenocar-cinoma in breast cancer patients receiving antiestrogens. Cancer Treat Rep 69(2):237-238
29. Kimura Y, Tojima H, Fukase S, Takeda K (1994) Clinical evaluation of sizofilan as assistant immunotherapy in treatment of head and neck cancer. Acta Otolaryngol Suppl 511:192-195
30. Kodama N, Komuta K, Nanba H (2002) Can maitake MD-fraction aid cancer patients? Altern Med Rev 7(3):236-239
31. Kodama N, Komuta K, Nanba H (2003) Effect of Maitake (Grifola frondosa) D-Fraction on the activation of NK cells in cancer patients. J Med Food 6(4):371-377
32. Komatsu N, Okubo S, Kikumoto S, Kimura K, Saito G (1969) Hostmediated antitumor action of schizophyllan, a glucan produced by Schizophyllum commune. Gann 60(2):137-144
33. Lee SH, Hwang HS, Yun JW (2009) Antitumor activity of water extract of a mushroom, Inonotus obliquus, against HT-29 human colon cancer cells. Phytother Res 23(12):1784-1789
34. Lehne G, Haneberg B, Gaustad P, Johansen PW, Preus H, Abraham-sen TG (2006) Oral administration of a new soluble branched beta-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers. Clin Exp Immunol 143(1):65-69
35. Lindequist U, Niedermeyer TH, Julich WD (2005) The pharmacological potential of mushrooms. Evid Based Complement Alternat Med 2(3):285-299
36. Mandlekar S, Yu R, Tan TH, Kong AN (2000) Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Cancer Res 60(21):5995-6000
37. Martin KR, Brophy SK (2010) Commonly consumed and specialty dietary mushrooms reduce cellular proliferation in MCF-7 human breast cancer cells. Exp Biol Med (Maywood) 235(11): 1306-1314
38. Miyazaki K, Mizutani H, Katabuchi H, Fukuma K, Fujisaki S, Okamura H (1995) Activated (HLA-DR+) T-lymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with sizofiran on cell-mediated immunity and survival. Gynecol Oncol 56(3):412-420
39. Nakano T, Oka K, Hanba K, Morita S (1996) Intratumoral administration of sizofiran activates Langerhans cell and T-cell infiltration in cervical cancer. Clin Immunol Immunopathol 79(1):79-86
40. Nemoto Y, Saibara T, Ogawa Y, Zhang T, Xu N, Ono M, Akisawa N, Iwasaki S, Maeda T, Onishi S (2002) Tamoxifen-induced nonalcoholic steatohepatitis in breast cancer patients treated with adjuvant tamoxifen. Intern Med 41(5):345-350
41. Noda K, Takeuchi S, Yajima A, Akiya K, Kasamatsu T, Tomoda Y, Ozawa M, Sekiba K, Sugimori H, Hashimoto S et al (1992) Clinical effect of sizofiran combined with irradiation in cervical cancer patients: a randomized controlled study. Cooperative study group on SPG for gynecological cancer. Jpn J Clin Oncol 22(1):17-25
42. Obrero M, Yu DV, Shapiro DJ (2002) Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen- induced programmed cell death. J Biol Chem 277(47):45695-45703
43. Okamura K, Suzuki M, Chihara T, Fujiwara A, Fukuda T, Goto S, Ichinohe K, Jimi S, Kasamatsu T, Kawai N et al (1989) Clinical evaluation of sizofiran combined with irradiation in patients with cervical cancer. A randomized controlled study; a five-year survival rate. Biotherapy 1(2):103-107
44. Ooi VE, Liu F (2000) Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 7(7):715-729
45. Osborne CK, Boldt DH, Clark GM, Trent JM (1983) Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res 43(8):3583-3585
46. Pogribny IP, Bagnyukova TV, Tryndyak VP, Muskhelishvili L, Rodriguez-Juarez R, Kovalchuk O, Han T, Fuscoe JC, Ross SA, Beland FA (2007) Gene expression profiling reveals underlying molecular mechanisms of the early stages of tamoxifen-induced rat hepatocarcinogenesis. Toxicol Appl Pharmacol 225(1):61-69
47. Rau U, Gura E, Olszewski E, Wagner F (1992) enhanced glucan formation of filamentous fungi by effective mixing, oxygen limitation and fed-batch processing. J Ind Microbiol 9(1):19-25
48. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ (1990) Comparative study of human and rat mammary tumorigenesis. Lab Invest 62(3):244-278
49. Shin A, Kim J, Lim SY, Kim G, Sung MK, Lee ES, Ro J (2010) Dietary mushroom intake and the risk of breast cancer based on hormone receptor status. Nutr Cancer 62(4):476-483
50. Sullivan R, Smith JE, Rowan NJ (2006) Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine. Perspect Biol Med 49(2):159-170
51. Tanji S, Akima K, Horiba M, Amemiya K, Aimoto T (1990) Studies on metabolism and disposition of sizofiran (SPG), an anti-tumor polysaccharide. III. Degradation and excretion of SPG in rats. Yakugaku Zasshi 110(11):869-875
52. Tokuyasu H, Takeda K, Kawasaki Y, Sakaguchi Y, Isowa N, Shimizu E, Ueda Y (2010) High plasma concentration of beta-D-glucan after administration of sizofiran for cervical cancer. Int J Gen Med 3:273-277
53. Tryndyak VP, Kovalchuk O, Muskhelishvili L, Montgomery B, Rodriguez-Juarez R, Melnyk S, Ross SA, Beland FA, Pogribny IP (2007) Epigenetic reprogramming of liver cells in tamoxifen-induced rat hepatocarcinogenesis. Mol Carcinog 46(3):187-197
54. Tsai-Turton M, Nakamura BN, Luderer U (2007) Induction of apoptosis by 9,10-dimethyl-1,2-benzanthracene in cultured preovulatory rat follicles is preceded by a rise in reactive oxygen species and is prevented by glutathione. Biol Reprod 77(3):442-451
55. Williams GM, Iatropoulos MJ, Karlsson S (1997) Initiating activity of the anti-estrogen tamoxifen, but not toremifene in rat liver. Carcinogenesis 18(11):2247-2253
56. Wu D, Pae M, Ren Z, Guo Z, Smith D, Meydani SN (2007) Dietary supplementation with white button mushroom enhances natural killer cell activity in C57BL/6 mice. J Nutr 137(6):1472-1477
57. Youn MJ, Kim JK, Park SY, Kim Y, Park C, Kim ES, Park KI, So HS, Park R (2009) Potential anticancer properties of the water extract of Inonotus [corrected] obliquus by induction of apop-tosis in melanoma B16-F10 cells. J Ethnopharmacol 121(2): 221-228
58. Yu L, Fernig DG, Smith JA, Milton JD, Rhodes JM (1993) Reversible inhibition of proliferation of epithelial cell lines by Agaricus bisporus (edible mushroom) lectin. Cancer Res 53(19):4627-4632
59. Zhang GJ, Kimijima I, Onda M, Kanno M, Sato H, Watanabe T, Tsuchiya A, Abe R, Takenoshita S (1999) Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels. Clin Cancer Res Off J Am Assoc Cancer Res 5(10): 2971-2977
60. Zhang M, Huang J, Xie X, Holman CD (2009) Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women. Int J Cancer 124(6):1404-1408